Kumar V, Panda BK. CAN COST OF PHARMACOLOGICAL THROMBOLYTIC THERAPY BE A MEDICATION MANAGEMENT STRATEGY FOR ACUTE CORONARY SYNDROME?. Asian J Pharm Clin Res [Internet]. 2017 Mar. 1 [cited 2024 Nov. 23];10(3):363-6. Available from: https://journals.innovareacademics.in/index.php/ajpcr/article/view/16308